AGEN EURO CAN BE FUN FOR ANYONE

Emily Bodnar’s ranking is based on the anticipation of significant milestones for Agenus in the coming 12 months, specially the potential submitting of the Biologics License Software (BLA) for his or her lead drug candidate, botensilimab (bot). Agenus has dosed above 900 clients with bot throughout various reliable tumors, displaying a motivation